ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686513 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686513; 2) Community: the network communities that were significantly associated with the response to NSC 686513; 3) Molecule: the relationships between components within communities and NSC 686513; 4) MDR: the compounds that were significantly associated with the NSC 686513.

NSC Compound Enrichment Correlation
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0203119150246197 0.37175449
NSC 633207 Null 0.0203119150246197 0.20464038
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.0203119150246197 -0.11182013
NSC 638241 Null 0.0203119150246197 0.39658397
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0203119150246197 0.47952815
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.0203119150246197 0.26410923
NSC 665622 Cyclohexanone, 2,6-bis[(1-pyrrolidinyl)methyl]-, dihydrochloride 0.0203119150246197 0.33847012
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.0203119150246197 0.50250724
NSC 668259 Null 0.0203119150246197 0.32775554
NSC 670784 Null 0.0203119150246197 0.29926494
Total:91  Current:45    [First] [Prev] [Next] [Last]